Evidence map›Paper›PMID 40205251›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025

Intensive care unit-acquired rectal colonization and subsequent infections with carbapenem-resistant bacteria: a cross-sectional study.

Suzan Şahin, Gülfem Akengin Öcal, Elif Bombacı, Serap Demir Tekol

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Suzan ŞahinDepartment of Infectious Diseases and Microbiology, Dr. Lütfi Kırdar Kartal City Hospital, 34865, Cevizli, Kartal, Istanbul, Türkiye. drsuzansahin@yahoo.com.ORCID http://orcid.org/0000-0002-7124-3363
Gülfem Akengin ÖcalDepartment of Infectious Diseases and Microbiology, Dr. Lütfi Kırdar Kartal City Hospital, 34865, Cevizli, Kartal, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-4923-4292
Elif BombacıDepartment of Anaesthesiology and Intensive Care, Dr. Lütfi Kırdar Kartal City Hospital, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-9153-140X
Serap Demir TekolDepartment of Microbiology, Dr. Lütfi Kırdar Kartal City Hospital, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-6525-1818

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNosocomial infections caused by carbapenem-resistant bacteria (CRB) present a worldwide threat. We examined the incidence and clinical outcomes of ICU-acquired gastrointestinal colonization with CRB detected through routine weekly surveillance of rectal swabs.

methodsThis retrospective study included adult patients admitted to the ICU between January 1, 2020 and December 31, 2022, whose rectal swab cultures yielded CRB colonization after at least 72 h of ICU admission.

resultsOf 4,673 eligible patients, 493 had at least one positive rectal swab culture for CRB (prevalence 10.5%) after a mean of 17.8 days from ICU admission. The most common CRB species was Klebsiella pneumoniae (41.8%), followed by Acinetobacter baumannii (32.3%), Pseudomonas aeruginosa (21.3%) and Escherichia coli (8.1%). Following colonization, 240 patients (48.7%) developed CRB infections after a mean of 11.4 days and 29.2 days from the first positive rectal culture and from ICU admission, respectively. The overall agreement between the baseline rectal and final cultures was 82.1%. CRB-infected patients had higher frequencies of burns at baseline (p < 0.001), carbapenem (p = 0.015) and colistin (p < 0.001) use during ICU stay, need for intubation (p = 0.002) and nasogastric tube (p = 0.021), prolonged ICU stay (p < 0.001), and mortality (p = 0.006).

conclusionOur findings showed that nearly one in every 10 ICU patients acquired CRB colonization despite preventive efforts, ending up with CRB infections in nearly half.

Indexed as

Anti-Bacterial AgentsBacteriaCarbapenemsCross InfectionIntensive Care UnitsRectumAdultAgedAged, 80 and overCross-Sectional StudiesDrug Resistance, BacterialFemaleHumansIncidenceMaleMiddle AgedAnti-Bacterial AgentsCarbapenemsCarbapenem-resistant bacteriaICU-acquired infectionsRectal colonizationRectal swabs

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.